Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Clinical trial NCT07295223 · RECRUITING
Trial details
- NCT number
- NCT07295223
- Sponsor
- Instituto Mexicano del Seguro Social
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2026-08-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.